nodes	percent_of_prediction	percent_of_DWPC	metapath
Olmesartan—SLCO1B1—Penicillamine—rheumatoid arthritis	0.375	0.498	CbGbCtD
Olmesartan—SLCO1B1—Sulfasalazine—rheumatoid arthritis	0.073	0.0969	CbGbCtD
Olmesartan—ABCC2—Sulfasalazine—rheumatoid arthritis	0.0641	0.0851	CbGbCtD
Olmesartan—SLCO1B1—Cyclosporine—rheumatoid arthritis	0.0553	0.0734	CbGbCtD
Olmesartan—SLCO1B3—Methotrexate—rheumatoid arthritis	0.0503	0.0667	CbGbCtD
Olmesartan—ABCC2—Cyclosporine—rheumatoid arthritis	0.0486	0.0645	CbGbCtD
Olmesartan—ABCC2—Dexamethasone—rheumatoid arthritis	0.032	0.0425	CbGbCtD
Olmesartan—SLCO1B1—Methotrexate—rheumatoid arthritis	0.0293	0.0388	CbGbCtD
Olmesartan—ABCC2—Methotrexate—rheumatoid arthritis	0.0257	0.0341	CbGbCtD
Olmesartan—SLCO1B1—SLC-mediated transmembrane transport—SLC22A4—rheumatoid arthritis	0.000199	0.00393	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CX3CR1—rheumatoid arthritis	0.000198	0.0039	CbGpPWpGaD
Olmesartan—AGTR1—G alpha (q) signalling events—RASGRP1—rheumatoid arthritis	0.000189	0.00373	CbGpPWpGaD
Olmesartan—AGTR1—G alpha (q) signalling events—PRKCQ—rheumatoid arthritis	0.000185	0.00365	CbGpPWpGaD
Olmesartan—SLCO1B3—SLC-mediated transmembrane transport—SLC11A1—rheumatoid arthritis	0.000185	0.00364	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—C5—rheumatoid arthritis	0.000184	0.00363	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—BDKRB2—rheumatoid arthritis	0.000182	0.00358	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—FADS2—rheumatoid arthritis	0.000181	0.00356	CbGpPWpGaD
Olmesartan—AGTR1—Allograft Rejection—IFNG—rheumatoid arthritis	0.00018	0.00356	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—ADRBK1—rheumatoid arthritis	0.00018	0.00354	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—PLD4—rheumatoid arthritis	0.000179	0.00354	CbGpPWpGaD
Olmesartan—AGTR1—Peptide ligand-binding receptors—CXCL10—rheumatoid arthritis	0.000177	0.00349	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR6—rheumatoid arthritis	0.000173	0.00341	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—rheumatoid arthritis	0.000169	0.00334	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—CXCL13—rheumatoid arthritis	0.000169	0.00333	CbGpPWpGaD
Olmesartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—rheumatoid arthritis	0.000168	0.00332	CbGpPWpGaD
Olmesartan—AGTR1—Allograft Rejection—CXCL8—rheumatoid arthritis	0.000168	0.00331	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—PRKCQ—rheumatoid arthritis	0.000166	0.00327	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—CXCL6—rheumatoid arthritis	0.000162	0.0032	CbGpPWpGaD
Olmesartan—AGTR1—Allograft Rejection—IL1B—rheumatoid arthritis	0.000161	0.00317	CbGpPWpGaD
Olmesartan—AGTR1—Allograft Rejection—IL2—rheumatoid arthritis	0.00016	0.00316	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—GC—rheumatoid arthritis	0.000159	0.00312	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—PTGES—rheumatoid arthritis	0.000159	0.00312	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL3—rheumatoid arthritis	0.000158	0.00312	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL2—rheumatoid arthritis	0.000158	0.00312	CbGpPWpGaD
Olmesartan—AGTR1—GPCRs, Class A Rhodopsin-like—BDKRB2—rheumatoid arthritis	0.000157	0.0031	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—LCN2—rheumatoid arthritis	0.000156	0.00307	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—SAA1—rheumatoid arthritis	0.000155	0.00305	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—CCL21—rheumatoid arthritis	0.000155	0.00305	CbGpPWpGaD
Olmesartan—AGTR1—Peptide ligand-binding receptors—CCL5—rheumatoid arthritis	0.000153	0.00301	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—CX3CR1—rheumatoid arthritis	0.000151	0.00297	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—SLC22A4—rheumatoid arthritis	0.000151	0.00297	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—PLB1—rheumatoid arthritis	0.000147	0.0029	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CXCL6—rheumatoid arthritis	0.000147	0.0029	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—rheumatoid arthritis	0.000146	0.00289	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—LCN2—rheumatoid arthritis	0.000146	0.00288	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CCL21—rheumatoid arthritis	0.00014	0.00277	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—C5—rheumatoid arthritis	0.00014	0.00276	CbGpPWpGaD
Olmesartan—AGTR1—Peptide ligand-binding receptors—CCR5—rheumatoid arthritis	0.000137	0.00271	CbGpPWpGaD
Olmesartan—AGTR1—Allograft Rejection—VEGFA—rheumatoid arthritis	0.000136	0.00268	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—BDKRB2—rheumatoid arthritis	0.000135	0.00265	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL12—rheumatoid arthritis	0.000135	0.00265	CbGpPWpGaD
Olmesartan—AGTR1—Peptide ligand-binding receptors—C3—rheumatoid arthritis	0.000134	0.00265	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—CCR6—rheumatoid arthritis	0.000132	0.0026	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—MED1—rheumatoid arthritis	0.000129	0.00255	CbGpPWpGaD
Olmesartan—AGTR1—Allograft Rejection—TGFB1—rheumatoid arthritis	0.000125	0.00246	CbGpPWpGaD
Olmesartan—Loss of consciousness—Betamethasone—rheumatoid arthritis	0.000124	0.000635	CcSEcCtD
Olmesartan—Rash—Leflunomide—rheumatoid arthritis	0.000124	0.000635	CcSEcCtD
Olmesartan—Tachycardia—Triamcinolone—rheumatoid arthritis	0.000124	0.000634	CcSEcCtD
Olmesartan—SLCO1B1—SLC-mediated transmembrane transport—SLC11A1—rheumatoid arthritis	0.000124	0.00245	CbGpPWpGaD
Olmesartan—Dermatitis—Leflunomide—rheumatoid arthritis	0.000124	0.000634	CcSEcCtD
Olmesartan—Mental disorder—Prednisone—rheumatoid arthritis	0.000124	0.000633	CcSEcCtD
Olmesartan—Nausea—Azathioprine—rheumatoid arthritis	0.000124	0.000633	CcSEcCtD
Olmesartan—Tachycardia—Methylprednisolone—rheumatoid arthritis	0.000124	0.000633	CcSEcCtD
Olmesartan—Headache—Leflunomide—rheumatoid arthritis	0.000123	0.000631	CcSEcCtD
Olmesartan—Skin disorder—Methylprednisolone—rheumatoid arthritis	0.000123	0.00063	CcSEcCtD
Olmesartan—Malnutrition—Prednisone—rheumatoid arthritis	0.000123	0.000629	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Hydrocortisone—rheumatoid arthritis	0.000123	0.000629	CcSEcCtD
Olmesartan—Hyperhidrosis—Triamcinolone—rheumatoid arthritis	0.000123	0.000628	CcSEcCtD
Olmesartan—Agranulocytosis—Methotrexate—rheumatoid arthritis	0.000123	0.000628	CcSEcCtD
Olmesartan—AGTR1—GPCR downstream signaling—PDE2A—rheumatoid arthritis	0.000123	0.00242	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—MED1—rheumatoid arthritis	0.000123	0.00242	CbGpPWpGaD
Olmesartan—Hyperhidrosis—Methylprednisolone—rheumatoid arthritis	0.000123	0.000627	CcSEcCtD
Olmesartan—Insomnia—Hydrocortisone—rheumatoid arthritis	0.000122	0.000624	CcSEcCtD
Olmesartan—Urticaria—Cyclosporine—rheumatoid arthritis	0.000121	0.000617	CcSEcCtD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PLD4—rheumatoid arthritis	0.000121	0.00238	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—CCL3—rheumatoid arthritis	0.000121	0.00237	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—CXCL2—rheumatoid arthritis	0.000121	0.00237	CbGpPWpGaD
Olmesartan—Myalgia—Betamethasone—rheumatoid arthritis	0.00012	0.000615	CcSEcCtD
Olmesartan—Myalgia—Dexamethasone—rheumatoid arthritis	0.00012	0.000615	CcSEcCtD
Olmesartan—Abdominal pain—Cyclosporine—rheumatoid arthritis	0.00012	0.000614	CcSEcCtD
Olmesartan—Body temperature increased—Cyclosporine—rheumatoid arthritis	0.00012	0.000614	CcSEcCtD
Olmesartan—Anxiety—Betamethasone—rheumatoid arthritis	0.00012	0.000613	CcSEcCtD
Olmesartan—Anxiety—Dexamethasone—rheumatoid arthritis	0.00012	0.000613	CcSEcCtD
Olmesartan—SLCO1B3—Metabolism—FADS2—rheumatoid arthritis	0.00012	0.00236	CbGpPWpGaD
Olmesartan—Discomfort—Dexamethasone—rheumatoid arthritis	0.000119	0.000608	CcSEcCtD
Olmesartan—Discomfort—Betamethasone—rheumatoid arthritis	0.000119	0.000608	CcSEcCtD
Olmesartan—Dyspepsia—Hydrocortisone—rheumatoid arthritis	0.000119	0.000608	CcSEcCtD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL10—rheumatoid arthritis	0.000119	0.00234	CbGpPWpGaD
Olmesartan—Hypotension—Methylprednisolone—rheumatoid arthritis	0.000119	0.000606	CcSEcCtD
Olmesartan—Pain—Prednisolone—rheumatoid arthritis	0.000118	0.000605	CcSEcCtD
Olmesartan—AGTR1—GPCR ligand binding—SAA1—rheumatoid arthritis	0.000118	0.00232	CbGpPWpGaD
Olmesartan—Decreased appetite—Hydrocortisone—rheumatoid arthritis	0.000117	0.0006	CcSEcCtD
Olmesartan—Pharyngitis—Methotrexate—rheumatoid arthritis	0.000117	0.0006	CcSEcCtD
Olmesartan—Nausea—Leflunomide—rheumatoid arthritis	0.000117	0.000598	CcSEcCtD
Olmesartan—Urinary tract disorder—Methotrexate—rheumatoid arthritis	0.000117	0.000597	CcSEcCtD
Olmesartan—AGTR1—Allograft Rejection—TNF—rheumatoid arthritis	0.000117	0.0023	CbGpPWpGaD
Olmesartan—Gastrointestinal disorder—Hydrocortisone—rheumatoid arthritis	0.000117	0.000596	CcSEcCtD
Olmesartan—Fatigue—Hydrocortisone—rheumatoid arthritis	0.000117	0.000595	CcSEcCtD
Olmesartan—Vision blurred—Prednisone—rheumatoid arthritis	0.000116	0.000593	CcSEcCtD
Olmesartan—Urethral disorder—Methotrexate—rheumatoid arthritis	0.000116	0.000592	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Triamcinolone—rheumatoid arthritis	0.000116	0.000592	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Methylprednisolone—rheumatoid arthritis	0.000116	0.000591	CcSEcCtD
Olmesartan—Pain—Hydrocortisone—rheumatoid arthritis	0.000116	0.00059	CcSEcCtD
Olmesartan—Oedema—Dexamethasone—rheumatoid arthritis	0.000115	0.00059	CcSEcCtD
Olmesartan—Anaphylactic shock—Dexamethasone—rheumatoid arthritis	0.000115	0.00059	CcSEcCtD
Olmesartan—Anaphylactic shock—Betamethasone—rheumatoid arthritis	0.000115	0.00059	CcSEcCtD
Olmesartan—Oedema—Betamethasone—rheumatoid arthritis	0.000115	0.00059	CcSEcCtD
Olmesartan—Insomnia—Triamcinolone—rheumatoid arthritis	0.000115	0.000588	CcSEcCtD
Olmesartan—Insomnia—Methylprednisolone—rheumatoid arthritis	0.000115	0.000587	CcSEcCtD
Olmesartan—Infection—Dexamethasone—rheumatoid arthritis	0.000115	0.000586	CcSEcCtD
Olmesartan—Infection—Betamethasone—rheumatoid arthritis	0.000115	0.000586	CcSEcCtD
Olmesartan—Ill-defined disorder—Prednisone—rheumatoid arthritis	0.000114	0.000584	CcSEcCtD
Olmesartan—Feeling abnormal—Prednisolone—rheumatoid arthritis	0.000114	0.000583	CcSEcCtD
Olmesartan—Anaemia—Prednisone—rheumatoid arthritis	0.000114	0.000582	CcSEcCtD
Olmesartan—Shock—Dexamethasone—rheumatoid arthritis	0.000114	0.00058	CcSEcCtD
Olmesartan—Shock—Betamethasone—rheumatoid arthritis	0.000114	0.00058	CcSEcCtD
Olmesartan—Nervous system disorder—Betamethasone—rheumatoid arthritis	0.000113	0.000578	CcSEcCtD
Olmesartan—Nervous system disorder—Dexamethasone—rheumatoid arthritis	0.000113	0.000578	CcSEcCtD
Olmesartan—Agitation—Prednisone—rheumatoid arthritis	0.000113	0.000578	CcSEcCtD
Olmesartan—Thrombocytopenia—Dexamethasone—rheumatoid arthritis	0.000113	0.000578	CcSEcCtD
Olmesartan—Thrombocytopenia—Betamethasone—rheumatoid arthritis	0.000113	0.000578	CcSEcCtD
Olmesartan—ABCC2—NRF2 pathway—AGER—rheumatoid arthritis	0.000113	0.00223	CbGpPWpGaD
Olmesartan—Tachycardia—Dexamethasone—rheumatoid arthritis	0.000113	0.000576	CcSEcCtD
Olmesartan—Tachycardia—Betamethasone—rheumatoid arthritis	0.000113	0.000576	CcSEcCtD
Olmesartan—Angioedema—Prednisone—rheumatoid arthritis	0.000113	0.000575	CcSEcCtD
Olmesartan—Dyspepsia—Triamcinolone—rheumatoid arthritis	0.000112	0.000572	CcSEcCtD
Olmesartan—Dyspepsia—Methylprednisolone—rheumatoid arthritis	0.000112	0.000571	CcSEcCtD
Olmesartan—Hyperhidrosis—Dexamethasone—rheumatoid arthritis	0.000112	0.00057	CcSEcCtD
Olmesartan—Hyperhidrosis—Betamethasone—rheumatoid arthritis	0.000112	0.00057	CcSEcCtD
Olmesartan—AGTR1—Signaling by GPCR—PDE2A—rheumatoid arthritis	0.000112	0.0022	CbGpPWpGaD
Olmesartan—Feeling abnormal—Hydrocortisone—rheumatoid arthritis	0.000111	0.000569	CcSEcCtD
Olmesartan—Malaise—Prednisone—rheumatoid arthritis	0.000111	0.000568	CcSEcCtD
Olmesartan—Vertigo—Prednisone—rheumatoid arthritis	0.000111	0.000566	CcSEcCtD
Olmesartan—Gastrointestinal pain—Hydrocortisone—rheumatoid arthritis	0.000111	0.000565	CcSEcCtD
Olmesartan—Syncope—Prednisone—rheumatoid arthritis	0.00011	0.000564	CcSEcCtD
Olmesartan—Anorexia—Betamethasone—rheumatoid arthritis	0.00011	0.000562	CcSEcCtD
Olmesartan—Anorexia—Dexamethasone—rheumatoid arthritis	0.00011	0.000562	CcSEcCtD
Olmesartan—Urticaria—Prednisolone—rheumatoid arthritis	0.00011	0.000562	CcSEcCtD
Olmesartan—Fatigue—Triamcinolone—rheumatoid arthritis	0.00011	0.00056	CcSEcCtD
Olmesartan—Fatigue—Methylprednisolone—rheumatoid arthritis	0.000109	0.000559	CcSEcCtD
Olmesartan—Asthenia—Cyclosporine—rheumatoid arthritis	0.000109	0.000557	CcSEcCtD
Olmesartan—Pain—Triamcinolone—rheumatoid arthritis	0.000109	0.000556	CcSEcCtD
Olmesartan—Loss of consciousness—Prednisone—rheumatoid arthritis	0.000108	0.000553	CcSEcCtD
Olmesartan—Hypotension—Dexamethasone—rheumatoid arthritis	0.000108	0.000551	CcSEcCtD
Olmesartan—Hypotension—Betamethasone—rheumatoid arthritis	0.000108	0.000551	CcSEcCtD
Olmesartan—ABCC2—Transmembrane transport of small molecules—SLC22A4—rheumatoid arthritis	0.000108	0.00213	CbGpPWpGaD
Olmesartan—AGTR1—GPCRs, Class A Rhodopsin-like—CCR5—rheumatoid arthritis	0.000108	0.00212	CbGpPWpGaD
Olmesartan—Pruritus—Cyclosporine—rheumatoid arthritis	0.000108	0.00055	CcSEcCtD
Olmesartan—AGTR1—Peptide ligand-binding receptors—POMC—rheumatoid arthritis	0.000107	0.00212	CbGpPWpGaD
Olmesartan—Urticaria—Hydrocortisone—rheumatoid arthritis	0.000107	0.000548	CcSEcCtD
Olmesartan—Angiopathy—Methotrexate—rheumatoid arthritis	0.000107	0.000548	CcSEcCtD
Olmesartan—Abdominal pain—Hydrocortisone—rheumatoid arthritis	0.000107	0.000546	CcSEcCtD
Olmesartan—Body temperature increased—Hydrocortisone—rheumatoid arthritis	0.000107	0.000546	CcSEcCtD
Olmesartan—Mediastinal disorder—Methotrexate—rheumatoid arthritis	0.000107	0.000545	CcSEcCtD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—GC—rheumatoid arthritis	0.000107	0.0021	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PTGES—rheumatoid arthritis	0.000107	0.0021	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6ST—rheumatoid arthritis	0.000106	0.0021	CbGpPWpGaD
Olmesartan—Musculoskeletal discomfort—Betamethasone—rheumatoid arthritis	0.000105	0.000537	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Dexamethasone—rheumatoid arthritis	0.000105	0.000537	CcSEcCtD
Olmesartan—AGTR1—Peptide ligand-binding receptors—CCL2—rheumatoid arthritis	0.000105	0.00207	CbGpPWpGaD
Olmesartan—Arthralgia—Prednisone—rheumatoid arthritis	0.000105	0.000536	CcSEcCtD
Olmesartan—Myalgia—Prednisone—rheumatoid arthritis	0.000105	0.000536	CcSEcCtD
Olmesartan—Feeling abnormal—Triamcinolone—rheumatoid arthritis	0.000105	0.000536	CcSEcCtD
Olmesartan—Feeling abnormal—Methylprednisolone—rheumatoid arthritis	0.000105	0.000535	CcSEcCtD
Olmesartan—Anxiety—Prednisone—rheumatoid arthritis	0.000105	0.000534	CcSEcCtD
Olmesartan—Alopecia—Methotrexate—rheumatoid arthritis	0.000105	0.000534	CcSEcCtD
Olmesartan—Insomnia—Dexamethasone—rheumatoid arthritis	0.000104	0.000534	CcSEcCtD
Olmesartan—Insomnia—Betamethasone—rheumatoid arthritis	0.000104	0.000534	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Prednisone—rheumatoid arthritis	0.000104	0.000532	CcSEcCtD
Olmesartan—Diarrhoea—Cyclosporine—rheumatoid arthritis	0.000104	0.000532	CcSEcCtD
Olmesartan—Gastrointestinal pain—Methylprednisolone—rheumatoid arthritis	0.000104	0.00053	CcSEcCtD
Olmesartan—Discomfort—Prednisone—rheumatoid arthritis	0.000104	0.000529	CcSEcCtD
Olmesartan—Mental disorder—Methotrexate—rheumatoid arthritis	0.000104	0.000529	CcSEcCtD
Olmesartan—Malnutrition—Methotrexate—rheumatoid arthritis	0.000103	0.000526	CcSEcCtD
Olmesartan—AGTR1—GPCR ligand binding—CXCL12—rheumatoid arthritis	0.000102	0.00202	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—BDKRB2—rheumatoid arthritis	0.000102	0.00202	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL5—rheumatoid arthritis	0.000102	0.00202	CbGpPWpGaD
Olmesartan—Dyspepsia—Betamethasone—rheumatoid arthritis	0.000102	0.000519	CcSEcCtD
Olmesartan—Dyspepsia—Dexamethasone—rheumatoid arthritis	0.000102	0.000519	CcSEcCtD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—SLC22A4—rheumatoid arthritis	0.000101	0.002	CbGpPWpGaD
Olmesartan—Urticaria—Triamcinolone—rheumatoid arthritis	0.000101	0.000516	CcSEcCtD
Olmesartan—Urticaria—Methylprednisolone—rheumatoid arthritis	0.000101	0.000515	CcSEcCtD
Olmesartan—Body temperature increased—Triamcinolone—rheumatoid arthritis	0.000101	0.000514	CcSEcCtD
Olmesartan—Dizziness—Cyclosporine—rheumatoid arthritis	0.000101	0.000514	CcSEcCtD
Olmesartan—Anaphylactic shock—Prednisone—rheumatoid arthritis	0.000101	0.000514	CcSEcCtD
Olmesartan—Oedema—Prednisone—rheumatoid arthritis	0.000101	0.000514	CcSEcCtD
Olmesartan—Abdominal pain—Methylprednisolone—rheumatoid arthritis	0.0001	0.000513	CcSEcCtD
Olmesartan—Decreased appetite—Dexamethasone—rheumatoid arthritis	0.0001	0.000513	CcSEcCtD
Olmesartan—Decreased appetite—Betamethasone—rheumatoid arthritis	0.0001	0.000513	CcSEcCtD
Olmesartan—Infection—Prednisone—rheumatoid arthritis	9.99e-05	0.00051	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Dexamethasone—rheumatoid arthritis	9.97e-05	0.000509	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Betamethasone—rheumatoid arthritis	9.97e-05	0.000509	CcSEcCtD
Olmesartan—Back pain—Methotrexate—rheumatoid arthritis	9.96e-05	0.000509	CcSEcCtD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—ALOX5—rheumatoid arthritis	9.96e-05	0.00196	CbGpPWpGaD
Olmesartan—Fatigue—Betamethasone—rheumatoid arthritis	9.95e-05	0.000509	CcSEcCtD
Olmesartan—Fatigue—Dexamethasone—rheumatoid arthritis	9.95e-05	0.000509	CcSEcCtD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PLB1—rheumatoid arthritis	9.9e-05	0.00195	CbGpPWpGaD
Olmesartan—Shock—Prednisone—rheumatoid arthritis	9.89e-05	0.000505	CcSEcCtD
Olmesartan—Pain—Betamethasone—rheumatoid arthritis	9.87e-05	0.000504	CcSEcCtD
Olmesartan—Pain—Dexamethasone—rheumatoid arthritis	9.87e-05	0.000504	CcSEcCtD
Olmesartan—Nervous system disorder—Prednisone—rheumatoid arthritis	9.86e-05	0.000504	CcSEcCtD
Olmesartan—Tachycardia—Prednisone—rheumatoid arthritis	9.81e-05	0.000501	CcSEcCtD
Olmesartan—Skin disorder—Prednisone—rheumatoid arthritis	9.77e-05	0.000499	CcSEcCtD
Olmesartan—Hyperhidrosis—Prednisone—rheumatoid arthritis	9.72e-05	0.000497	CcSEcCtD
Olmesartan—Vision blurred—Methotrexate—rheumatoid arthritis	9.7e-05	0.000496	CcSEcCtD
Olmesartan—Asthenia—Hydrocortisone—rheumatoid arthritis	9.7e-05	0.000495	CcSEcCtD
Olmesartan—Vomiting—Cyclosporine—rheumatoid arthritis	9.67e-05	0.000494	CcSEcCtD
Olmesartan—Rash—Cyclosporine—rheumatoid arthritis	9.59e-05	0.00049	CcSEcCtD
Olmesartan—Anorexia—Prednisone—rheumatoid arthritis	9.58e-05	0.00049	CcSEcCtD
Olmesartan—Dermatitis—Cyclosporine—rheumatoid arthritis	9.58e-05	0.000489	CcSEcCtD
Olmesartan—Pruritus—Hydrocortisone—rheumatoid arthritis	9.56e-05	0.000488	CcSEcCtD
Olmesartan—AGTR1—GPCR downstream signaling—CXCL13—rheumatoid arthritis	9.56e-05	0.00188	CbGpPWpGaD
Olmesartan—Ill-defined disorder—Methotrexate—rheumatoid arthritis	9.55e-05	0.000488	CcSEcCtD
Olmesartan—Headache—Cyclosporine—rheumatoid arthritis	9.53e-05	0.000487	CcSEcCtD
Olmesartan—Anaemia—Methotrexate—rheumatoid arthritis	9.52e-05	0.000486	CcSEcCtD
Olmesartan—Feeling abnormal—Betamethasone—rheumatoid arthritis	9.51e-05	0.000486	CcSEcCtD
Olmesartan—Feeling abnormal—Dexamethasone—rheumatoid arthritis	9.51e-05	0.000486	CcSEcCtD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—rheumatoid arthritis	9.5e-05	0.00187	CbGpPWpGaD
Olmesartan—Gastrointestinal pain—Dexamethasone—rheumatoid arthritis	9.44e-05	0.000482	CcSEcCtD
Olmesartan—Gastrointestinal pain—Betamethasone—rheumatoid arthritis	9.44e-05	0.000482	CcSEcCtD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—SLC11A1—rheumatoid arthritis	9.39e-05	0.00185	CbGpPWpGaD
Olmesartan—Malaise—Methotrexate—rheumatoid arthritis	9.29e-05	0.000474	CcSEcCtD
Olmesartan—Vertigo—Methotrexate—rheumatoid arthritis	9.25e-05	0.000473	CcSEcCtD
Olmesartan—Diarrhoea—Hydrocortisone—rheumatoid arthritis	9.25e-05	0.000472	CcSEcCtD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR5—rheumatoid arthritis	9.22e-05	0.00182	CbGpPWpGaD
Olmesartan—Leukopenia—Methotrexate—rheumatoid arthritis	9.22e-05	0.000471	CcSEcCtD
Olmesartan—Urticaria—Dexamethasone—rheumatoid arthritis	9.17e-05	0.000469	CcSEcCtD
Olmesartan—Urticaria—Betamethasone—rheumatoid arthritis	9.17e-05	0.000469	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Prednisone—rheumatoid arthritis	9.16e-05	0.000468	CcSEcCtD
Olmesartan—Dizziness—Prednisolone—rheumatoid arthritis	9.15e-05	0.000467	CcSEcCtD
Olmesartan—Asthenia—Triamcinolone—rheumatoid arthritis	9.13e-05	0.000466	CcSEcCtD
Olmesartan—Body temperature increased—Dexamethasone—rheumatoid arthritis	9.13e-05	0.000466	CcSEcCtD
Olmesartan—Abdominal pain—Dexamethasone—rheumatoid arthritis	9.13e-05	0.000466	CcSEcCtD
Olmesartan—Abdominal pain—Betamethasone—rheumatoid arthritis	9.13e-05	0.000466	CcSEcCtD
Olmesartan—Body temperature increased—Betamethasone—rheumatoid arthritis	9.13e-05	0.000466	CcSEcCtD
Olmesartan—Asthenia—Methylprednisolone—rheumatoid arthritis	9.11e-05	0.000465	CcSEcCtD
Olmesartan—Insomnia—Prednisone—rheumatoid arthritis	9.09e-05	0.000465	CcSEcCtD
Olmesartan—AGTR1—GPCR ligand binding—CXCL10—rheumatoid arthritis	9.06e-05	0.00178	CbGpPWpGaD
Olmesartan—Nausea—Cyclosporine—rheumatoid arthritis	9.03e-05	0.000461	CcSEcCtD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—C3—rheumatoid arthritis	9.01e-05	0.00178	CbGpPWpGaD
Olmesartan—Pruritus—Triamcinolone—rheumatoid arthritis	9e-05	0.00046	CcSEcCtD
Olmesartan—Cough—Methotrexate—rheumatoid arthritis	8.99e-05	0.000459	CcSEcCtD
Olmesartan—Pruritus—Methylprednisolone—rheumatoid arthritis	8.98e-05	0.000459	CcSEcCtD
Olmesartan—Dizziness—Hydrocortisone—rheumatoid arthritis	8.94e-05	0.000457	CcSEcCtD
Olmesartan—Dyspepsia—Prednisone—rheumatoid arthritis	8.85e-05	0.000452	CcSEcCtD
Olmesartan—ABCC2—Transmembrane transport of small molecules—MED1—rheumatoid arthritis	8.79e-05	0.00173	CbGpPWpGaD
Olmesartan—Chest pain—Methotrexate—rheumatoid arthritis	8.77e-05	0.000448	CcSEcCtD
Olmesartan—Arthralgia—Methotrexate—rheumatoid arthritis	8.77e-05	0.000448	CcSEcCtD
Olmesartan—Myalgia—Methotrexate—rheumatoid arthritis	8.77e-05	0.000448	CcSEcCtD
Olmesartan—Decreased appetite—Prednisone—rheumatoid arthritis	8.74e-05	0.000447	CcSEcCtD
Olmesartan—Rash—Prednisolone—rheumatoid arthritis	8.72e-05	0.000446	CcSEcCtD
Olmesartan—Dermatitis—Prednisolone—rheumatoid arthritis	8.72e-05	0.000445	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—rheumatoid arthritis	8.71e-05	0.000445	CcSEcCtD
Olmesartan—AGTR1—Signaling Pathways—CXCL6—rheumatoid arthritis	8.7e-05	0.00171	CbGpPWpGaD
Olmesartan—Diarrhoea—Methylprednisolone—rheumatoid arthritis	8.69e-05	0.000444	CcSEcCtD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—MED1—rheumatoid arthritis	8.68e-05	0.00171	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CXCL13—rheumatoid arthritis	8.68e-05	0.00171	CbGpPWpGaD
Olmesartan—Fatigue—Prednisone—rheumatoid arthritis	8.67e-05	0.000443	CcSEcCtD
Olmesartan—Headache—Prednisolone—rheumatoid arthritis	8.67e-05	0.000443	CcSEcCtD
Olmesartan—Discomfort—Methotrexate—rheumatoid arthritis	8.66e-05	0.000442	CcSEcCtD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—rheumatoid arthritis	8.65e-05	0.0017	CbGpPWpGaD
Olmesartan—Constipation—Prednisone—rheumatoid arthritis	8.6e-05	0.000439	CcSEcCtD
Olmesartan—Vomiting—Hydrocortisone—rheumatoid arthritis	8.59e-05	0.000439	CcSEcCtD
Olmesartan—Rash—Hydrocortisone—rheumatoid arthritis	8.52e-05	0.000435	CcSEcCtD
Olmesartan—Dermatitis—Hydrocortisone—rheumatoid arthritis	8.51e-05	0.000435	CcSEcCtD
Olmesartan—Headache—Hydrocortisone—rheumatoid arthritis	8.47e-05	0.000433	CcSEcCtD
Olmesartan—Dizziness—Triamcinolone—rheumatoid arthritis	8.42e-05	0.00043	CcSEcCtD
Olmesartan—Anaphylactic shock—Methotrexate—rheumatoid arthritis	8.4e-05	0.000429	CcSEcCtD
Olmesartan—Dizziness—Methylprednisolone—rheumatoid arthritis	8.4e-05	0.000429	CcSEcCtD
Olmesartan—Infection—Methotrexate—rheumatoid arthritis	8.35e-05	0.000427	CcSEcCtD
Olmesartan—AGTR1—Peptide ligand-binding receptors—CXCL8—rheumatoid arthritis	8.31e-05	0.00164	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CCL21—rheumatoid arthritis	8.3e-05	0.00164	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—SYVN1—rheumatoid arthritis	8.3e-05	0.00164	CbGpPWpGaD
Olmesartan—Feeling abnormal—Prednisone—rheumatoid arthritis	8.29e-05	0.000423	CcSEcCtD
Olmesartan—Asthenia—Dexamethasone—rheumatoid arthritis	8.28e-05	0.000423	CcSEcCtD
Olmesartan—Asthenia—Betamethasone—rheumatoid arthritis	8.28e-05	0.000423	CcSEcCtD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—MED1—rheumatoid arthritis	8.26e-05	0.00163	CbGpPWpGaD
Olmesartan—Nervous system disorder—Methotrexate—rheumatoid arthritis	8.24e-05	0.000421	CcSEcCtD
Olmesartan—Thrombocytopenia—Methotrexate—rheumatoid arthritis	8.23e-05	0.00042	CcSEcCtD
Olmesartan—Gastrointestinal pain—Prednisone—rheumatoid arthritis	8.22e-05	0.00042	CcSEcCtD
Olmesartan—Nausea—Prednisolone—rheumatoid arthritis	8.22e-05	0.00042	CcSEcCtD
Olmesartan—AGTR1—GPCR downstream signaling—IL2RB—rheumatoid arthritis	8.2e-05	0.00162	CbGpPWpGaD
Olmesartan—Pruritus—Betamethasone—rheumatoid arthritis	8.17e-05	0.000417	CcSEcCtD
Olmesartan—Pruritus—Dexamethasone—rheumatoid arthritis	8.17e-05	0.000417	CcSEcCtD
Olmesartan—Skin disorder—Methotrexate—rheumatoid arthritis	8.16e-05	0.000417	CcSEcCtD
Olmesartan—Hyperhidrosis—Methotrexate—rheumatoid arthritis	8.12e-05	0.000415	CcSEcCtD
Olmesartan—Vomiting—Triamcinolone—rheumatoid arthritis	8.09e-05	0.000413	CcSEcCtD
Olmesartan—Vomiting—Methylprednisolone—rheumatoid arthritis	8.07e-05	0.000412	CcSEcCtD
Olmesartan—SLCO1B1—Metabolism—FADS2—rheumatoid arthritis	8.05e-05	0.00159	CbGpPWpGaD
Olmesartan—Nausea—Hydrocortisone—rheumatoid arthritis	8.03e-05	0.00041	CcSEcCtD
Olmesartan—Rash—Triamcinolone—rheumatoid arthritis	8.02e-05	0.00041	CcSEcCtD
Olmesartan—Dermatitis—Triamcinolone—rheumatoid arthritis	8.02e-05	0.00041	CcSEcCtD
Olmesartan—Anorexia—Methotrexate—rheumatoid arthritis	8.01e-05	0.000409	CcSEcCtD
Olmesartan—Rash—Methylprednisolone—rheumatoid arthritis	8.01e-05	0.000409	CcSEcCtD
Olmesartan—Dermatitis—Methylprednisolone—rheumatoid arthritis	8e-05	0.000409	CcSEcCtD
Olmesartan—SLCO1B3—Metabolism—PLD4—rheumatoid arthritis	7.99e-05	0.00158	CbGpPWpGaD
Olmesartan—Urticaria—Prednisone—rheumatoid arthritis	7.99e-05	0.000408	CcSEcCtD
Olmesartan—Headache—Triamcinolone—rheumatoid arthritis	7.97e-05	0.000407	CcSEcCtD
Olmesartan—AGTR1—Signaling Pathways—TAGAP—rheumatoid arthritis	7.96e-05	0.00157	CbGpPWpGaD
Olmesartan—Headache—Methylprednisolone—rheumatoid arthritis	7.95e-05	0.000406	CcSEcCtD
Olmesartan—Abdominal pain—Prednisone—rheumatoid arthritis	7.95e-05	0.000406	CcSEcCtD
Olmesartan—Body temperature increased—Prednisone—rheumatoid arthritis	7.95e-05	0.000406	CcSEcCtD
Olmesartan—AGTR1—GPCR downstream signaling—C5—rheumatoid arthritis	7.92e-05	0.00156	CbGpPWpGaD
Olmesartan—Diarrhoea—Dexamethasone—rheumatoid arthritis	7.9e-05	0.000404	CcSEcCtD
Olmesartan—Diarrhoea—Betamethasone—rheumatoid arthritis	7.9e-05	0.000404	CcSEcCtD
Olmesartan—Hypotension—Methotrexate—rheumatoid arthritis	7.85e-05	0.000401	CcSEcCtD
Olmesartan—AGTR1—GPCR ligand binding—CCL5—rheumatoid arthritis	7.8e-05	0.00154	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CX3CR1—rheumatoid arthritis	7.74e-05	0.00152	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ACAN—rheumatoid arthritis	7.72e-05	0.00152	CbGpPWpGaD
Olmesartan—Musculoskeletal discomfort—Methotrexate—rheumatoid arthritis	7.66e-05	0.000391	CcSEcCtD
Olmesartan—Dizziness—Betamethasone—rheumatoid arthritis	7.64e-05	0.00039	CcSEcCtD
Olmesartan—Dizziness—Dexamethasone—rheumatoid arthritis	7.64e-05	0.00039	CcSEcCtD
Olmesartan—Insomnia—Methotrexate—rheumatoid arthritis	7.6e-05	0.000388	CcSEcCtD
Olmesartan—Nausea—Triamcinolone—rheumatoid arthritis	7.56e-05	0.000386	CcSEcCtD
Olmesartan—Nausea—Methylprednisolone—rheumatoid arthritis	7.54e-05	0.000385	CcSEcCtD
Olmesartan—AGTR1—Signaling by GPCR—IL2RB—rheumatoid arthritis	7.45e-05	0.00147	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—CCR6—rheumatoid arthritis	7.45e-05	0.00147	CbGpPWpGaD
Olmesartan—Dyspepsia—Methotrexate—rheumatoid arthritis	7.4e-05	0.000378	CcSEcCtD
Olmesartan—Vomiting—Betamethasone—rheumatoid arthritis	7.34e-05	0.000375	CcSEcCtD
Olmesartan—Vomiting—Dexamethasone—rheumatoid arthritis	7.34e-05	0.000375	CcSEcCtD
Olmesartan—Decreased appetite—Methotrexate—rheumatoid arthritis	7.31e-05	0.000373	CcSEcCtD
Olmesartan—Rash—Dexamethasone—rheumatoid arthritis	7.28e-05	0.000372	CcSEcCtD
Olmesartan—Rash—Betamethasone—rheumatoid arthritis	7.28e-05	0.000372	CcSEcCtD
Olmesartan—Dermatitis—Dexamethasone—rheumatoid arthritis	7.27e-05	0.000372	CcSEcCtD
Olmesartan—Dermatitis—Betamethasone—rheumatoid arthritis	7.27e-05	0.000372	CcSEcCtD
Olmesartan—SLCO1B3—Metabolism—SLC25A12—rheumatoid arthritis	7.26e-05	0.00143	CbGpPWpGaD
Olmesartan—Gastrointestinal disorder—Methotrexate—rheumatoid arthritis	7.26e-05	0.000371	CcSEcCtD
Olmesartan—Fatigue—Methotrexate—rheumatoid arthritis	7.25e-05	0.00037	CcSEcCtD
Olmesartan—Headache—Betamethasone—rheumatoid arthritis	7.23e-05	0.00037	CcSEcCtD
Olmesartan—Headache—Dexamethasone—rheumatoid arthritis	7.23e-05	0.00037	CcSEcCtD
Olmesartan—Asthenia—Prednisone—rheumatoid arthritis	7.21e-05	0.000369	CcSEcCtD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—POMC—rheumatoid arthritis	7.21e-05	0.00142	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—C5—rheumatoid arthritis	7.19e-05	0.00142	CbGpPWpGaD
Olmesartan—Pain—Methotrexate—rheumatoid arthritis	7.19e-05	0.000367	CcSEcCtD
Olmesartan—Pruritus—Prednisone—rheumatoid arthritis	7.11e-05	0.000363	CcSEcCtD
Olmesartan—SLCO1B3—Metabolism—PTGES—rheumatoid arthritis	7.06e-05	0.00139	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—GC—rheumatoid arthritis	7.06e-05	0.00139	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL2—rheumatoid arthritis	7.05e-05	0.00139	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—CCR5—rheumatoid arthritis	7.02e-05	0.00138	CbGpPWpGaD
Olmesartan—Feeling abnormal—Methotrexate—rheumatoid arthritis	6.93e-05	0.000354	CcSEcCtD
Olmesartan—Diarrhoea—Prednisone—rheumatoid arthritis	6.88e-05	0.000351	CcSEcCtD
Olmesartan—Gastrointestinal pain—Methotrexate—rheumatoid arthritis	6.87e-05	0.000351	CcSEcCtD
Olmesartan—AGTR1—GPCR ligand binding—C3—rheumatoid arthritis	6.86e-05	0.00135	CbGpPWpGaD
Olmesartan—Nausea—Dexamethasone—rheumatoid arthritis	6.86e-05	0.00035	CcSEcCtD
Olmesartan—Nausea—Betamethasone—rheumatoid arthritis	6.86e-05	0.00035	CcSEcCtD
Olmesartan—AGTR1—GPCR downstream signaling—CXCL2—rheumatoid arthritis	6.81e-05	0.00134	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CCR6—rheumatoid arthritis	6.76e-05	0.00133	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—SLC11A1—rheumatoid arthritis	6.72e-05	0.00132	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—ALOX5—rheumatoid arthritis	6.69e-05	0.00132	CbGpPWpGaD
Olmesartan—Urticaria—Methotrexate—rheumatoid arthritis	6.68e-05	0.000341	CcSEcCtD
Olmesartan—AGTR1—GPCR downstream signaling—SAA1—rheumatoid arthritis	6.66e-05	0.00131	CbGpPWpGaD
Olmesartan—SLCO1B3—SLC-mediated transmembrane transport—ALB—rheumatoid arthritis	6.65e-05	0.00131	CbGpPWpGaD
Olmesartan—Dizziness—Prednisone—rheumatoid arthritis	6.65e-05	0.00034	CcSEcCtD
Olmesartan—Body temperature increased—Methotrexate—rheumatoid arthritis	6.64e-05	0.000339	CcSEcCtD
Olmesartan—Abdominal pain—Methotrexate—rheumatoid arthritis	6.64e-05	0.000339	CcSEcCtD
Olmesartan—AGTR1—Signaling Pathways—PDE2A—rheumatoid arthritis	6.59e-05	0.0013	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PLB1—rheumatoid arthritis	6.56e-05	0.00129	CbGpPWpGaD
Olmesartan—Vomiting—Prednisone—rheumatoid arthritis	6.39e-05	0.000327	CcSEcCtD
Olmesartan—Rash—Prednisone—rheumatoid arthritis	6.34e-05	0.000324	CcSEcCtD
Olmesartan—Dermatitis—Prednisone—rheumatoid arthritis	6.33e-05	0.000324	CcSEcCtD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—SLC11A1—rheumatoid arthritis	6.31e-05	0.00124	CbGpPWpGaD
Olmesartan—Headache—Prednisone—rheumatoid arthritis	6.3e-05	0.000322	CcSEcCtD
Olmesartan—AGTR1—Signaling Pathways—PLB1—rheumatoid arthritis	6.29e-05	0.00124	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CCL3—rheumatoid arthritis	6.18e-05	0.00122	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CXCL2—rheumatoid arthritis	6.18e-05	0.00122	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—SAA1—rheumatoid arthritis	6.05e-05	0.00119	CbGpPWpGaD
Olmesartan—Asthenia—Methotrexate—rheumatoid arthritis	6.03e-05	0.000308	CcSEcCtD
Olmesartan—Nausea—Prednisone—rheumatoid arthritis	5.97e-05	0.000305	CcSEcCtD
Olmesartan—Pruritus—Methotrexate—rheumatoid arthritis	5.95e-05	0.000304	CcSEcCtD
Olmesartan—AGTR1—Signaling Pathways—RBPJ—rheumatoid arthritis	5.8e-05	0.00114	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—BDKRB2—rheumatoid arthritis	5.79e-05	0.00114	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—CXCL12—rheumatoid arthritis	5.79e-05	0.00114	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—MED1—rheumatoid arthritis	5.76e-05	0.00113	CbGpPWpGaD
Olmesartan—Diarrhoea—Methotrexate—rheumatoid arthritis	5.75e-05	0.000294	CcSEcCtD
Olmesartan—AGTR1—GPCR downstream signaling—ADRBK1—rheumatoid arthritis	5.73e-05	0.00113	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—rheumatoid arthritis	5.58e-05	0.0011	CbGpPWpGaD
Olmesartan—Dizziness—Methotrexate—rheumatoid arthritis	5.56e-05	0.000284	CcSEcCtD
Olmesartan—AGTR1—GPCR ligand binding—POMC—rheumatoid arthritis	5.49e-05	0.00108	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—RASGRP1—rheumatoid arthritis	5.4e-05	0.00106	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—CCL2—rheumatoid arthritis	5.37e-05	0.00106	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PLD4—rheumatoid arthritis	5.37e-05	0.00106	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—B3GNT2—rheumatoid arthritis	5.35e-05	0.00105	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ACP5—rheumatoid arthritis	5.35e-05	0.00105	CbGpPWpGaD
Olmesartan—Vomiting—Methotrexate—rheumatoid arthritis	5.34e-05	0.000273	CcSEcCtD
Olmesartan—Rash—Methotrexate—rheumatoid arthritis	5.3e-05	0.000271	CcSEcCtD
Olmesartan—Dermatitis—Methotrexate—rheumatoid arthritis	5.29e-05	0.00027	CcSEcCtD
Olmesartan—AGTR1—GPCR downstream signaling—PRKCQ—rheumatoid arthritis	5.28e-05	0.00104	CbGpPWpGaD
Olmesartan—Headache—Methotrexate—rheumatoid arthritis	5.26e-05	0.000269	CcSEcCtD
Olmesartan—AGTR1—Signaling by GPCR—BDKRB2—rheumatoid arthritis	5.26e-05	0.00104	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CXCL12—rheumatoid arthritis	5.26e-05	0.00104	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—ADRBK1—rheumatoid arthritis	5.2e-05	0.00102	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ACAN—rheumatoid arthritis	5.19e-05	0.00102	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CXCL13—rheumatoid arthritis	5.13e-05	0.00101	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—CXCL10—rheumatoid arthritis	5.12e-05	0.00101	CbGpPWpGaD
Olmesartan—Nausea—Methotrexate—rheumatoid arthritis	4.99e-05	0.000255	CcSEcCtD
Olmesartan—AGTR1—Signaling by GPCR—RASGRP1—rheumatoid arthritis	4.9e-05	0.000967	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—SLC25A12—rheumatoid arthritis	4.88e-05	0.000961	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—BGN—rheumatoid arthritis	4.82e-05	0.000949	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—PRKCQ—rheumatoid arthritis	4.8e-05	0.000946	CbGpPWpGaD
Olmesartan—ABCC2—NRF2 pathway—TGFB1—rheumatoid arthritis	4.78e-05	0.000941	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GC—rheumatoid arthritis	4.74e-05	0.000935	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PTGES—rheumatoid arthritis	4.74e-05	0.000935	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CXCL10—rheumatoid arthritis	4.65e-05	0.000916	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IRAK1—rheumatoid arthritis	4.62e-05	0.00091	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—TLE3—rheumatoid arthritis	4.62e-05	0.00091	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CX3CR1—rheumatoid arthritis	4.57e-05	0.000901	CbGpPWpGaD
Olmesartan—SLCO1B1—SLC-mediated transmembrane transport—ALB—rheumatoid arthritis	4.47e-05	0.000881	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ALOX5—rheumatoid arthritis	4.43e-05	0.000874	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PLB1—rheumatoid arthritis	4.41e-05	0.000869	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—CCL5—rheumatoid arthritis	4.41e-05	0.000868	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IL2RB—rheumatoid arthritis	4.4e-05	0.000867	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—CSF2—rheumatoid arthritis	4.34e-05	0.000855	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—C5—rheumatoid arthritis	4.25e-05	0.000837	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—CXCL8—rheumatoid arthritis	4.25e-05	0.000837	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—MMP3—rheumatoid arthritis	4.24e-05	0.000835	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—rheumatoid arthritis	4.23e-05	0.000834	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NFATC1—rheumatoid arthritis	4.18e-05	0.000824	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CCL5—rheumatoid arthritis	4e-05	0.000788	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CCR6—rheumatoid arthritis	3.99e-05	0.000787	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—CCR5—rheumatoid arthritis	3.97e-05	0.000782	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CSF2—rheumatoid arthritis	3.94e-05	0.000777	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—IL2RA—rheumatoid arthritis	3.91e-05	0.000771	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	3.9e-05	0.000768	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NCF2—rheumatoid arthritis	3.89e-05	0.000766	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—C3—rheumatoid arthritis	3.88e-05	0.000764	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—MED1—rheumatoid arthritis	3.87e-05	0.000762	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—TRAF6—rheumatoid arthritis	3.79e-05	0.000746	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—SH2B3—rheumatoid arthritis	3.79e-05	0.000746	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—GZMB—rheumatoid arthritis	3.76e-05	0.000742	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CXCL2—rheumatoid arthritis	3.65e-05	0.00072	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CCL3—rheumatoid arthritis	3.65e-05	0.00072	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ENO1—rheumatoid arthritis	3.61e-05	0.000712	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CCR5—rheumatoid arthritis	3.6e-05	0.00071	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—B3GNT2—rheumatoid arthritis	3.59e-05	0.000708	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ACP5—rheumatoid arthritis	3.59e-05	0.000708	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—SAA1—rheumatoid arthritis	3.57e-05	0.000704	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	3.55e-05	0.000701	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—IL2RA—rheumatoid arthritis	3.55e-05	0.0007	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—C3—rheumatoid arthritis	3.52e-05	0.000694	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NCF1—rheumatoid arthritis	3.5e-05	0.000689	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—ALB—rheumatoid arthritis	3.38e-05	0.000666	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CD28—rheumatoid arthritis	3.36e-05	0.000663	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—BGN—rheumatoid arthritis	3.24e-05	0.000638	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—UBE2D1—rheumatoid arthritis	3.17e-05	0.000624	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	3.11e-05	0.000613	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—BDKRB2—rheumatoid arthritis	3.11e-05	0.000612	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CXCL12—rheumatoid arthritis	3.11e-05	0.000612	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—POMC—rheumatoid arthritis	3.1e-05	0.000611	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—IL6ST—rheumatoid arthritis	3.08e-05	0.000607	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—ADRBK1—rheumatoid arthritis	3.07e-05	0.000605	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ALOX5—rheumatoid arthritis	2.98e-05	0.000587	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—RASGRP1—rheumatoid arthritis	2.9e-05	0.000571	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—SYK—rheumatoid arthritis	2.89e-05	0.000569	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PRKCQ—rheumatoid arthritis	2.83e-05	0.000559	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—POMC—rheumatoid arthritis	2.82e-05	0.000555	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—STAT1—rheumatoid arthritis	2.78e-05	0.000549	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CCL2—rheumatoid arthritis	2.76e-05	0.000543	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—IL6R—rheumatoid arthritis	2.75e-05	0.000542	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CXCL10—rheumatoid arthritis	2.75e-05	0.000541	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	2.62e-05	0.000516	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CAT—rheumatoid arthritis	2.6e-05	0.000513	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—MMP3—rheumatoid arthritis	2.5e-05	0.000493	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—TYK2—rheumatoid arthritis	2.5e-05	0.000493	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ENO1—rheumatoid arthritis	2.43e-05	0.000479	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—ALB—rheumatoid arthritis	2.42e-05	0.000477	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PTK2—rheumatoid arthritis	2.41e-05	0.000475	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—CXCL8—rheumatoid arthritis	2.4e-05	0.000473	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	2.39e-05	0.000471	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CCL5—rheumatoid arthritis	2.36e-05	0.000466	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CSF2—rheumatoid arthritis	2.33e-05	0.000459	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—IL2—rheumatoid arthritis	2.29e-05	0.000452	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—ALB—rheumatoid arthritis	2.27e-05	0.000448	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—SPP1—rheumatoid arthritis	2.19e-05	0.000431	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CXCL8—rheumatoid arthritis	2.18e-05	0.000429	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—MTHFR—rheumatoid arthritis	2.17e-05	0.000428	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CCR5—rheumatoid arthritis	2.13e-05	0.00042	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IL2RA—rheumatoid arthritis	2.1e-05	0.000414	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	2.09e-05	0.000412	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—IL2—rheumatoid arthritis	2.08e-05	0.00041	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—C3—rheumatoid arthritis	2.08e-05	0.00041	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—LEP—rheumatoid arthritis	1.94e-05	0.000382	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—FN1—rheumatoid arthritis	1.83e-05	0.00036	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IL6ST—rheumatoid arthritis	1.82e-05	0.000359	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CD80—rheumatoid arthritis	1.75e-05	0.000345	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CAT—rheumatoid arthritis	1.75e-05	0.000344	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—POMC—rheumatoid arthritis	1.74e-05	0.000342	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—POMC—rheumatoid arthritis	1.66e-05	0.000328	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CCL2—rheumatoid arthritis	1.63e-05	0.000321	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IL6R—rheumatoid arthritis	1.62e-05	0.00032	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ALB—rheumatoid arthritis	1.58e-05	0.000312	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—NOS3—rheumatoid arthritis	1.51e-05	0.000298	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—TYK2—rheumatoid arthritis	1.48e-05	0.000291	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—MTHFR—rheumatoid arthritis	1.46e-05	0.000287	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NOS3—rheumatoid arthritis	1.45e-05	0.000286	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PTGS2—rheumatoid arthritis	1.39e-05	0.000273	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CXCL8—rheumatoid arthritis	1.29e-05	0.000254	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IL2—rheumatoid arthritis	1.23e-05	0.000242	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—IL6—rheumatoid arthritis	1.22e-05	0.000241	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—POMC—rheumatoid arthritis	1.17e-05	0.00023	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—MMP9—rheumatoid arthritis	1.16e-05	0.000229	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NFKB1—rheumatoid arthritis	1.15e-05	0.000227	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—MAPK8—rheumatoid arthritis	1.13e-05	0.000223	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ALB—rheumatoid arthritis	1.06e-05	0.00021	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—VEGFA—rheumatoid arthritis	1.05e-05	0.000206	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—NOS3—rheumatoid arthritis	1.02e-05	0.000201	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—TGFB1—rheumatoid arthritis	9.6e-06	0.000189	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PTGS2—rheumatoid arthritis	9.31e-06	0.000183	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—TP53—rheumatoid arthritis	7.9e-06	0.000156	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IL6—rheumatoid arthritis	7.23e-06	0.000142	CbGpPWpGaD
